tiprankstipranks
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Australian Market
AVE
Avecho Biotechnology Limited
RESEARCH TOOLSreports
Want to see AU:AVE full AI Analyst Report?

Avecho Biotechnology Limited (AVE) Stock News & Sentiment

11 Followers
Avecho readies Phase III interim analysis on CBD insomnia capsule amid surging sleep market
Premium
Company Announcements
Avecho readies Phase III interim analysis on CBD insomnia capsule amid surging sleep market
5h ago
Avecho Secures A$1.98m R&D Tax Refund to Advance CBD Insomnia Program
Premium
Company Announcements
Avecho Secures A$1.98m R&D Tax Refund to Advance CBD Insomnia Program
3d ago
Avecho hits key milestone in Phase III CBD insomnia trial ahead of interim data
Premium
Company Announcements
Avecho hits key milestone in Phase III CBD insomnia trial ahead of interim data
4d ago
Avecho director reshapes indirect stake as options exercised and lapse
Premium
Company Announcements
Avecho director reshapes indirect stake as options exercised and lapse
12d ago
Avecho seeks ASX quotation for nearly 150m new shares
Premium
Company Announcements
Avecho seeks ASX quotation for nearly 150m new shares
12d ago
Avecho lifts cash and streamlines capital ahead of pivotal CBD insomnia trial milestone
Premium
Company Announcements
Avecho lifts cash and streamlines capital ahead of pivotal CBD insomnia trial milestone
13d ago
Avecho Seeks ASX Quotation for Newly Issued Shares
Premium
Company Announcements
Avecho Seeks ASX Quotation for Newly Issued Shares
18d ago
More AU:AVE News >

AVE News on the Web

Avecho to Showcase CBD Insomnia Program at NWR Healthcare Conference
TipRanks News
Bullish
Tony#8217;s Takeaway: Trading three tenors
StockHead
Bullish
Health Check: It#8217;s an A-plus for revenue, a D-minus for profitability
StockHead
Bullish
Avecho hits key Phase III recruitment milestone in CBD insomnia trial
TipRanks News
Bullish
Avecho Files Updated Corporate Governance Statement and Appendix 4G with ASX
TipRanks News
Bearish
Avecho Widens Annual Loss Despite Higher Revenue as Development Spending Continues
TipRanks News
Neutral
Investor Guide: Health #038; Biotech 2026 featuring Tim Boreham
StockHead
Neutral
Avecho nears key Phase III milestone as CEO showcases CBD insomnia program at healthcare forum
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
AU:AVE
Sector Average
Media Buzz
This Week6 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:AVE’s Media Buzz Sentiment?
6 articles about AU:AVE were published this week. In an average week, 2.75 articles are published.
    What is AU:AVE’s weekly average amount of articles?
    In an average week, 2.75 articles about AU:AVE are published.
      What is AU:AVE’s News Sentiment?
      100% of articles about AU:AVE were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week